Cough Suppressant Drugs Market Synopsis:
Cough Suppressant Drugs Market Size Was Valued at USD 1.4 Billion in 2023, and is Projected to Reach USD 2.0 Billion by 2032, Growing at a CAGR of 3.8% From 2024-2032.
The Cough Suppressant Drugs Market refers to the analysis of the effective drugs used in limiting or in the complete stoppage of coughing. These drugs only act on the brain sites of cough, and they suppress the cough reflex of the brain. They find frequent use in the treatment of ailments like the common cold, flu and other respiratory diseases that causing coughing.
The worldwide market for cough suppressant drugs is expected to grow steadily as more people seek good treatment for pathological cough conditions and acute cough. The market is chiefly propelled majorly by increasing instances of respiratory diseases which include common cold, the flu and more severe disorders including asthma and bronchitis. The common flue is known to cause coughe, therefore there is always going to be constant demand for the products that help to ease this ail. Moreover, growing air pollution, smoking tendencies, and life style diseases, like COPD are fostering the market of cough suppressant drugs.
Cough medicines can be categorized into prescription cough medicines and counter (OTC) products. OTC products are normally believed to be used by persons with mild ailments such as dry cough, while prescription drugs are believed to be used by persons with severe conditions. This segmentation due to an expansion of the number of people who prefer to self-treat cough and gain more knowledge of cough treatment. Furthermore, a variety of drug formulations such as syrup, tablet and lozenge has created convenient to customers to select their preferred products. However, some of the issues being experienced in the market include; regulation, misuse of some ingredients such as codeine in prescription drugs, and competition from natural products.
Cough Suppressant Drugs Market Trend Analysis:
Increasing Self-medication with OTC Products
-
The use of medicines without a doctor’s prescription, particularly OTC cough suppressants has been on the rise in recent years. General healthcare costs are increasing, while consumers increasingly shun doctors’ trips for even mild ailments hence using OTC drugs to treat coughs and colds. These products are widely available and relatively inexpensive and are promoted as having few side effects; therefore, are appreciated by people who need fast and easy remedies. This has also been backed by increase in online pharmacy stores, e-commerce companies, where consumer can by the OTC cough suppressants without consulting with a doctor.
-
However, self-medication is on the rise and comes with issues like misuse and overuse of some cough suppressants which contain some ingredients that are not restricted in some Countries where laws that ban some drugs are not well implemented. This has in turn put pressure on health authorities to provide awareness of right consumption of these drugs to avoid the pitfalls that could be manifested in dependency on narcotic based suppressants like codeine among others. Despite these challenges, the tendency towards self-medication is expected to persist driving the market most actively in the developed regions with higher levels of disposable income and more active attitude towards health management
Expansion of Natural Cough Suppressant Products
-
The market for cough suppressant drugs has a good potential for natural or herbal cure. Nowadays, more and more emphasis on using organic products and natural products to cure day to day ailments such as coughs. Such change is due to various reasons such as side effects as well as the negative impacts of taking synthetic substances in the body for an extended period. Home remedy cough products like those with honey, menthol, and herbs like licorice root and eucalyptus are becoming popular as most people in such regions rely on natural products.
-
Such opportunities reveal modern firms’ enhanced production and commercialization of cough suppressant systems based on natural components and minimal chemical components. These products are especially attractive to people who use products derived from organic or plant origin or who are worried about the negative effects of synthetic chemicals to the environment or to human body. Besides, these natural products may have other uses because they can reduce throat irritation and improve respiratory health. As such, consumer demand for such products offers manufacturers a considerable opportunity to seize new share in this still nascent segment of the cough suppressant market.
Cough Suppressant Drugs Market Segment Analysis:
Cough Suppressant Drugs Market Segmented on the basis of drug type, formulation, active ingredient, distribution channel, application, end user, distribution channel, and region.
By Drug Type, Prescription-Based Cough Suppressants segment is expected to dominate the market during the forecast period
-
Cough suppressants based on prescription are usually recommended for more severe forms or COPD where the cough is continuous and extremely painful. Many of these products include narcotic substances, for example, codeine, they act effectively but have the potential for development of drug dependence. The availability of prescription-based cough suppressants to the public has also been a thorny issue to some regulatory bodies around the world and as such its market potential is a bit constrained.
-
However, prescription cough medicines are compressed by over the counter cough suppressants regarding market volume as most customers prefer self-diagnosed treatment. These products are mostly taken in coughs that accompany cold or seasonal flu and are known to be safer for use without prescription. They include products like dextromethorphan, menthol or guaifenesin products, if they cause a cough or a sore throat. These products are growing due to the increase in the availability of health-conscious consumers.
By Application, Dry Cough segment expected to held the largest share
-
The Dry Cough segment is expected to hold the largest share of the Cough Suppressant Drugs Market due to its widespread prevalence and increasing incidence of respiratory infections and environmental pollutants. Dry cough, characterized by the absence of mucus, is commonly associated with viral infections, allergies, and irritants, driving demand for effective symptom relief. The growing awareness among consumers regarding over-the-counter (OTC) medications and the availability of a wide range of dry cough-specific suppressants further supports market growth. Additionally, pharmaceutical companies are focusing on developing innovative, fast-acting formulations tailored for dry cough relief. These factors, coupled with increased healthcare spending and self-medication trends, contribute significantly to the dominance of the dry cough segment within the global cough suppressant drugs market.
Cough Suppressant Drugs Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
North America is the largest market for cough suppressant drugs. This is particularly because of the costs of healthcare in the region, enhanced health care systems, and products allowed in the market and accessibility of numerous cough suppressant products. Reasons include; high level of awareness concerning respiratory health across the majority of consumers, a tremendous market for prescription as well as over the counter drugs, and the existence of a vibrant pharmaceutical market in North America. Furthermore, high geriatric population prevalence and high incidences of respiratory diseases such as asthma and chronic obstructive pulmonary disease enhance long-term demand for the therapeutic cough remedies.
-
Thus, the support of the regulation also contributes significantly to the market in North America. Government health departments including the U.S. FDA also check on that those cough suppressant products are safe for use. Transportation has also gained easier since the increase in online pharmacies and e-commerce stores in North America. They collectively contribute to attributing of North America alone a considerable market shares worldwide; let alone that the leadership in the market share is anticipated to remain intact in the near forecast.
Active Key Players in the Cough Suppressant Drugs Market
- AbbVie (USA)
- Bayer (Germany)
- Eli Lilly (USA)
- GlaxoSmithKline (UK)
- Johnson & Johnson (USA)
- Merck & Co. (USA)
- Mylan (USA)
- Novartis (Switzerland)
- Pfizer (USA)
- Reckitt Benckiser (UK)
- Sanofi (France)
- Teva Pharmaceutical Industries (Israel)
- Other Active Players
|
Global Cough Suppressant Drugs Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 1.4 Billion |
|
Forecast Period 2024-32 CAGR: |
3.8% |
Market Size in 2032: |
USD 2.0 Billion |
|
Segments Covered: |
By Drug Type |
|
|
|
By Formulation |
|
||
|
By Active Ingredient |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Cough Suppressant Drugs Market by Drug Type
4.1 Cough Suppressant Drugs Market Snapshot and Growth Engine
4.2 Cough Suppressant Drugs Market Overview
4.3 Prescription-Based Cough Suppressants
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Prescription-Based Cough Suppressants: Geographic Segmentation Analysis
4.4 Over-the-Counter (OTC) Cough Suppressants
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Over-the-Counter (OTC) Cough Suppressants: Geographic Segmentation Analysis
Chapter 5: Cough Suppressant Drugs Market by Formulation
5.1 Cough Suppressant Drugs Market Snapshot and Growth Engine
5.2 Cough Suppressant Drugs Market Overview
5.3 Tablets
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Tablets: Geographic Segmentation Analysis
5.4 Syrups
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Syrups: Geographic Segmentation Analysis
5.5 Lozenges
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Lozenges: Geographic Segmentation Analysis
5.6 Sprays
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Sprays: Geographic Segmentation Analysis
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation Analysis
Chapter 6: Cough Suppressant Drugs Market by Active Ingredient
6.1 Cough Suppressant Drugs Market Snapshot and Growth Engine
6.2 Cough Suppressant Drugs Market Overview
6.3 Dextromethorphan
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Dextromethorphan: Geographic Segmentation Analysis
6.4 Codeine
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Codeine: Geographic Segmentation Analysis
6.5 Benzonatate
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Benzonatate: Geographic Segmentation Analysis
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation Analysis
Chapter 7: Cough Suppressant Drugs Market by Application
7.1 Cough Suppressant Drugs Market Snapshot and Growth Engine
7.2 Cough Suppressant Drugs Market Overview
7.3 Dry Cough
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Dry Cough: Geographic Segmentation Analysis
7.4 Productive Cough
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Productive Cough: Geographic Segmentation Analysis
Chapter 8: Cough Suppressant Drugs Market by End User
8.1 Cough Suppressant Drugs Market Snapshot and Growth Engine
8.2 Cough Suppressant Drugs Market Overview
8.3 Hospitals & Clinics
8.3.1 Introduction and Market Overview
8.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
8.3.3 Key Market Trends, Growth Factors and Opportunities
8.3.4 Hospitals & Clinics: Geographic Segmentation Analysis
8.4 Retail Pharmacies
8.4.1 Introduction and Market Overview
8.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
8.4.3 Key Market Trends, Growth Factors and Opportunities
8.4.4 Retail Pharmacies: Geographic Segmentation Analysis
8.5 Online Pharmacies
8.5.1 Introduction and Market Overview
8.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
8.5.3 Key Market Trends, Growth Factors and Opportunities
8.5.4 Online Pharmacies: Geographic Segmentation Analysis
8.6 Others
8.6.1 Introduction and Market Overview
8.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
8.6.3 Key Market Trends, Growth Factors and Opportunities
8.6.4 Others: Geographic Segmentation Analysis
Chapter 9: Cough Suppressant Drugs Market by Distribution Channel
9.1 Cough Suppressant Drugs Market Snapshot and Growth Engine
9.2 Cough Suppressant Drugs Market Overview
9.3 Direct Sales
9.3.1 Introduction and Market Overview
9.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
9.3.3 Key Market Trends, Growth Factors and Opportunities
9.3.4 Direct Sales: Geographic Segmentation Analysis
9.4 Third-Party Distribution
9.4.1 Introduction and Market Overview
9.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
9.4.3 Key Market Trends, Growth Factors and Opportunities
9.4.4 Third-Party Distribution: Geographic Segmentation Analysis
Chapter 10: Company Profiles and Competitive Analysis
10.1 Competitive Landscape
10.1.1 Competitive Benchmarking
10.1.2 Cough Suppressant Drugs Market Share by Manufacturer (2023)
10.1.3 Industry BCG Matrix
10.1.4 Heat Map Analysis
10.1.5 Mergers and Acquisitions
10.2 JOHNSON & JOHNSON (USA)
10.2.1 Company Overview
10.2.2 Key Executives
10.2.3 Company Snapshot
10.2.4 Role of the Company in the Market
10.2.5 Sustainability and Social Responsibility
10.2.6 Operating Business Segments
10.2.7 Product Portfolio
10.2.8 Business Performance
10.2.9 Key Strategic Moves and Recent Developments
10.2.10 SWOT Analysis
10.3 GLAXOSMITHKLINE (UK)
10.4 PFIZER (USA)
10.5 NOVARTIS (SWITZERLAND)
10.6 BAYER (GERMANY)
10.7 MYLAN (USA)
10.8 SANOFI (FRANCE)
10.9 RECKITT BENCKISER (UK)
10.10 ELI LILLY (USA)
10.11 ABBVIE (USA)
MERCK & CO. (USA)
10.12 TEVA PHARMACEUTICAL INDUSTRIES (ISRAEL)
10.13 OTHER ACTIVE PLAYERS
Chapter 11: Global Cough Suppressant Drugs Market By Region
11.1 Overview
11.2. North America Cough Suppressant Drugs Market
11.2.1 Key Market Trends, Growth Factors and Opportunities
11.2.2 Top Key Companies
11.2.3 Historic and Forecasted Market Size by Segments
11.2.4 Historic and Forecasted Market Size By Drug Type
11.2.4.1 Prescription-Based Cough Suppressants
11.2.4.2 Over-the-Counter (OTC) Cough Suppressants
11.2.5 Historic and Forecasted Market Size By Formulation
11.2.5.1 Tablets
11.2.5.2 Syrups
11.2.5.3 Lozenges
11.2.5.4 Sprays
11.2.5.5 Others
11.2.6 Historic and Forecasted Market Size By Active Ingredient
11.2.6.1 Dextromethorphan
11.2.6.2 Codeine
11.2.6.3 Benzonatate
11.2.6.4 Others
11.2.7 Historic and Forecasted Market Size By Application
11.2.7.1 Dry Cough
11.2.7.2 Productive Cough
11.2.8 Historic and Forecasted Market Size By End User
11.2.8.1 Hospitals & Clinics
11.2.8.2 Retail Pharmacies
11.2.8.3 Online Pharmacies
11.2.8.4 Others
11.2.9 Historic and Forecasted Market Size By Distribution Channel
11.2.9.1 Direct Sales
11.2.9.2 Third-Party Distribution
11.2.10 Historic and Forecast Market Size by Country
11.2.10.1 US
11.2.10.2 Canada
11.2.10.3 Mexico
11.3. Eastern Europe Cough Suppressant Drugs Market
11.3.1 Key Market Trends, Growth Factors and Opportunities
11.3.2 Top Key Companies
11.3.3 Historic and Forecasted Market Size by Segments
11.3.4 Historic and Forecasted Market Size By Drug Type
11.3.4.1 Prescription-Based Cough Suppressants
11.3.4.2 Over-the-Counter (OTC) Cough Suppressants
11.3.5 Historic and Forecasted Market Size By Formulation
11.3.5.1 Tablets
11.3.5.2 Syrups
11.3.5.3 Lozenges
11.3.5.4 Sprays
11.3.5.5 Others
11.3.6 Historic and Forecasted Market Size By Active Ingredient
11.3.6.1 Dextromethorphan
11.3.6.2 Codeine
11.3.6.3 Benzonatate
11.3.6.4 Others
11.3.7 Historic and Forecasted Market Size By Application
11.3.7.1 Dry Cough
11.3.7.2 Productive Cough
11.3.8 Historic and Forecasted Market Size By End User
11.3.8.1 Hospitals & Clinics
11.3.8.2 Retail Pharmacies
11.3.8.3 Online Pharmacies
11.3.8.4 Others
11.3.9 Historic and Forecasted Market Size By Distribution Channel
11.3.9.1 Direct Sales
11.3.9.2 Third-Party Distribution
11.3.10 Historic and Forecast Market Size by Country
11.3.10.1 Russia
11.3.10.2 Bulgaria
11.3.10.3 The Czech Republic
11.3.10.4 Hungary
11.3.10.5 Poland
11.3.10.6 Romania
11.3.10.7 Rest of Eastern Europe
11.4. Western Europe Cough Suppressant Drugs Market
11.4.1 Key Market Trends, Growth Factors and Opportunities
11.4.2 Top Key Companies
11.4.3 Historic and Forecasted Market Size by Segments
11.4.4 Historic and Forecasted Market Size By Drug Type
11.4.4.1 Prescription-Based Cough Suppressants
11.4.4.2 Over-the-Counter (OTC) Cough Suppressants
11.4.5 Historic and Forecasted Market Size By Formulation
11.4.5.1 Tablets
11.4.5.2 Syrups
11.4.5.3 Lozenges
11.4.5.4 Sprays
11.4.5.5 Others
11.4.6 Historic and Forecasted Market Size By Active Ingredient
11.4.6.1 Dextromethorphan
11.4.6.2 Codeine
11.4.6.3 Benzonatate
11.4.6.4 Others
11.4.7 Historic and Forecasted Market Size By Application
11.4.7.1 Dry Cough
11.4.7.2 Productive Cough
11.4.8 Historic and Forecasted Market Size By End User
11.4.8.1 Hospitals & Clinics
11.4.8.2 Retail Pharmacies
11.4.8.3 Online Pharmacies
11.4.8.4 Others
11.4.9 Historic and Forecasted Market Size By Distribution Channel
11.4.9.1 Direct Sales
11.4.9.2 Third-Party Distribution
11.4.10 Historic and Forecast Market Size by Country
11.4.10.1 Germany
11.4.10.2 UK
11.4.10.3 France
11.4.10.4 The Netherlands
11.4.10.5 Italy
11.4.10.6 Spain
11.4.10.7 Rest of Western Europe
11.5. Asia Pacific Cough Suppressant Drugs Market
11.5.1 Key Market Trends, Growth Factors and Opportunities
11.5.2 Top Key Companies
11.5.3 Historic and Forecasted Market Size by Segments
11.5.4 Historic and Forecasted Market Size By Drug Type
11.5.4.1 Prescription-Based Cough Suppressants
11.5.4.2 Over-the-Counter (OTC) Cough Suppressants
11.5.5 Historic and Forecasted Market Size By Formulation
11.5.5.1 Tablets
11.5.5.2 Syrups
11.5.5.3 Lozenges
11.5.5.4 Sprays
11.5.5.5 Others
11.5.6 Historic and Forecasted Market Size By Active Ingredient
11.5.6.1 Dextromethorphan
11.5.6.2 Codeine
11.5.6.3 Benzonatate
11.5.6.4 Others
11.5.7 Historic and Forecasted Market Size By Application
11.5.7.1 Dry Cough
11.5.7.2 Productive Cough
11.5.8 Historic and Forecasted Market Size By End User
11.5.8.1 Hospitals & Clinics
11.5.8.2 Retail Pharmacies
11.5.8.3 Online Pharmacies
11.5.8.4 Others
11.5.9 Historic and Forecasted Market Size By Distribution Channel
11.5.9.1 Direct Sales
11.5.9.2 Third-Party Distribution
11.5.10 Historic and Forecast Market Size by Country
11.5.10.1 China
11.5.10.2 India
11.5.10.3 Japan
11.5.10.4 South Korea
11.5.10.5 Malaysia
11.5.10.6 Thailand
11.5.10.7 Vietnam
11.5.10.8 The Philippines
11.5.10.9 Australia
11.5.10.10 New Zealand
11.5.10.11 Rest of APAC
11.6. Middle East & Africa Cough Suppressant Drugs Market
11.6.1 Key Market Trends, Growth Factors and Opportunities
11.6.2 Top Key Companies
11.6.3 Historic and Forecasted Market Size by Segments
11.6.4 Historic and Forecasted Market Size By Drug Type
11.6.4.1 Prescription-Based Cough Suppressants
11.6.4.2 Over-the-Counter (OTC) Cough Suppressants
11.6.5 Historic and Forecasted Market Size By Formulation
11.6.5.1 Tablets
11.6.5.2 Syrups
11.6.5.3 Lozenges
11.6.5.4 Sprays
11.6.5.5 Others
11.6.6 Historic and Forecasted Market Size By Active Ingredient
11.6.6.1 Dextromethorphan
11.6.6.2 Codeine
11.6.6.3 Benzonatate
11.6.6.4 Others
11.6.7 Historic and Forecasted Market Size By Application
11.6.7.1 Dry Cough
11.6.7.2 Productive Cough
11.6.8 Historic and Forecasted Market Size By End User
11.6.8.1 Hospitals & Clinics
11.6.8.2 Retail Pharmacies
11.6.8.3 Online Pharmacies
11.6.8.4 Others
11.6.9 Historic and Forecasted Market Size By Distribution Channel
11.6.9.1 Direct Sales
11.6.9.2 Third-Party Distribution
11.6.10 Historic and Forecast Market Size by Country
11.6.10.1 Turkiye
11.6.10.2 Bahrain
11.6.10.3 Kuwait
11.6.10.4 Saudi Arabia
11.6.10.5 Qatar
11.6.10.6 UAE
11.6.10.7 Israel
11.6.10.8 South Africa
11.7. South America Cough Suppressant Drugs Market
11.7.1 Key Market Trends, Growth Factors and Opportunities
11.7.2 Top Key Companies
11.7.3 Historic and Forecasted Market Size by Segments
11.7.4 Historic and Forecasted Market Size By Drug Type
11.7.4.1 Prescription-Based Cough Suppressants
11.7.4.2 Over-the-Counter (OTC) Cough Suppressants
11.7.5 Historic and Forecasted Market Size By Formulation
11.7.5.1 Tablets
11.7.5.2 Syrups
11.7.5.3 Lozenges
11.7.5.4 Sprays
11.7.5.5 Others
11.7.6 Historic and Forecasted Market Size By Active Ingredient
11.7.6.1 Dextromethorphan
11.7.6.2 Codeine
11.7.6.3 Benzonatate
11.7.6.4 Others
11.7.7 Historic and Forecasted Market Size By Application
11.7.7.1 Dry Cough
11.7.7.2 Productive Cough
11.7.8 Historic and Forecasted Market Size By End User
11.7.8.1 Hospitals & Clinics
11.7.8.2 Retail Pharmacies
11.7.8.3 Online Pharmacies
11.7.8.4 Others
11.7.9 Historic and Forecasted Market Size By Distribution Channel
11.7.9.1 Direct Sales
11.7.9.2 Third-Party Distribution
11.7.10 Historic and Forecast Market Size by Country
11.7.10.1 Brazil
11.7.10.2 Argentina
11.7.10.3 Rest of SA
Chapter 12 Analyst Viewpoint and Conclusion
12.1 Recommendations and Concluding Analysis
12.2 Potential Market Strategies
Chapter 13 Research Methodology
13.1 Research Process
13.2 Primary Research
13.3 Secondary Research
|
Global Cough Suppressant Drugs Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 1.4 Billion |
|
Forecast Period 2024-32 CAGR: |
3.8% |
Market Size in 2032: |
USD 2.0 Billion |
|
Segments Covered: |
By Drug Type |
|
|
|
By Formulation |
|
||
|
By Active Ingredient |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
|
Global Cough Suppressant Drugs Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 1.4 Billion |
|
Forecast Period 2024-32 CAGR: |
3.8% |
Market Size in 2032: |
USD 2.0 Billion |
|
Segments Covered: |
By Drug Type |
|
|
|
By Formulation |
|
||
|
By Active Ingredient |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
